SBI Life Insurance Company Limited (SBILIFE.NS)
Mumbai, IN
SBI Life Insurance Company Limited functions as a private life insurer operating across India. The firm provides a broad portfolio of life and health coverage, tailored for both individual clients and group entities. Its offerings include participating and non-participating policies, pension schemes, and a variety of group benefits such as gratuity, leave encashment, and superannuation. Additionally, the company offers unit-linked and variable insurance products, health insurance, micro-insurance, and specific protections like accident, disability, level term, and critical illness policies. Distribution is facilitated via a comprehensive multi-channel network comprising independent agents, brokers, corporate representatives, bancassurance alliances, and certified insurance facilitators. As of March 31, 2022, this extensive network supported approximately 35,500 partner branches. Established in 2000, SBI Life is headquartered in Mumbai, India, and operates as a subsidiary of the State Bank of India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.76% | -3.76% | -7.16% | -10.42% | -15.79% | -16.16% | -2.80% | +37.22% | +73.00% | +141.11% | +141.11% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 5 | 0 |
| Buy | 31 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%-3.1% Q1'26: -80.9% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%+2.3% Q1'26: -1.1% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+2.2% Q1'26: +352.5% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+2.3% Q1'26: +19.8% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%+15.6% ★ Q1'26: +20.3% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%+0.1% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 21 Rev. Ana. 28 EPS Ana. |
Mar 2027 24 Rev. Ana. 28 EPS Ana. |
Mar 2028 25 Rev. Ana. 28 EPS Ana. |
Mar 2029 9 Rev. Ana. 9 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
339.61B
est: 285.47B (+19.0%)
|
445.27B
est: 335.87B (+32.6%)
|
437.39B
est: 431.26B (+1.4%)
|
821.22B
est: 593.78B (+38.3%)
|
829.11B
est: 827.90B (+0.1%)
|
806.39B
est: 909.25B (-11.3%)
|
1.31T
est: 1.39T (-5.7%)
|
1.15T
est: 894.51B (+29.0%)
|
989.58B
903.53B – 1.06T
+10.6% YoY
|
1.16T
953.03B – 1.28T
+17.5% YoY
|
1.33T
1.02T – 1.51T
+14.2% YoY
|
1.50T
1.19T – 1.68T
+13.2% YoY
|
| EBITDA |
12.50B
est: 5.77B (+116.5%)
|
14.72B
est: 16.61B (-11.4%)
|
15.11B
est: 18.60B (-18.8%)
|
16.63B
est: 16.51B (+0.8%)
|
16.58B
est: 20.32B (-18.4%)
|
18.51B
est: 20.92B (-11.5%)
|
20.27B
est: 28.74B (-29.5%)
|
25.90B
est: 18.29B (+41.6%)
|
20.50B
18.71B – 22.05B
+12.1% YoY
|
24.08B
19.74B – 26.43B
+17.5% YoY
|
27.49B
21.13B – 31.25B
+14.2% YoY
|
31.13B
24.67B – 34.82B
+13.2% YoY
|
| EBIT |
11.91B
est: 5.53B (+115.3%)
|
13.81B
est: 13.95B (-1.0%)
|
14.22B
est: 18.11B (-21.5%)
|
15.64B
est: 20.38B (-23.3%)
|
15.83B
est: 25.09B (-36.9%)
|
17.83B
est: 25.83B (-31.0%)
|
19.51B
est: 27.90B (-30.1%)
|
25.06B
est: 17.75B (+41.2%)
|
19.89B
18.16B – 21.40B
+12.1% YoY
|
23.37B
19.16B – 25.65B
+17.5% YoY
|
26.68B
20.51B – 30.33B
+14.2% YoY
|
30.21B
23.94B – 33.79B
+13.2% YoY
|
| Net Income |
11.50B
est: 11.38B (+1.1%)
|
13.27B
est: 14.45B (-8.2%)
|
14.22B
est: 17.27B (-17.7%)
|
14.56B
est: 16.09B (-9.5%)
|
15.06B
est: 19.81B (-24.0%)
|
17.21B
est: 20.39B (-15.6%)
|
18.94B
est: 20.32B (-6.8%)
|
24.13B
est: 24.88B (-3.0%)
|
24.70B
19.61B – 38.36B
-0.7% YoY
|
29.07B
23.17B – 38.45B
+17.7% YoY
|
33.71B
27.87B – 52.09B
+16.0% YoY
|
37.61B
31.86B – 47.73B
+11.6% YoY
|
| SGA |
16.18B
est: 971.28M (+1,565.7%)
|
19.76B
est: 27.37B (-27.8%)
|
22.57B
est: 34.84B (-35.2%)
|
22.31B
est: 35.71B (-37.5%)
|
27.94B
est: 43.97B (-36.4%)
|
31.73B
est: 45.27B (-29.9%)
|
37.85B
est: 38.53B (-1.8%)
|
42.55B
est: 24.52B (+73.6%)
|
27.48B
25.09B – 29.56B
+12.1% YoY
|
32.28B
26.46B – 35.43B
+17.5% YoY
|
36.85B
28.33B – 41.89B
+14.2% YoY
|
41.74B
33.07B – 46.68B
+13.2% YoY
|
| EPS |
11.50
est: 11.35 (+1.3%)
|
13.27
est: 13.29 (-0.1%)
|
14.22
est: 14.49 (-1.8%)
|
14.56
est: 15.09 (-3.5%)
|
15.06
est: 15.46 (-2.6%)
|
17.19
est: 17.35 (-0.9%)
|
18.92
est: 20.30 (-6.8%)
|
24.09
est: 23.36 (+3.1%)
|
26.93
19.54 – 38.23
+15.3% YoY
|
30.43
23.10 – 38.32
+13.0% YoY
|
35.54
27.78 – 51.91
+16.8% YoY
|
40.09
31.75 – 47.57
+12.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-11 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-10 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-09 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-08 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-05 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-04 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-03 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-02 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-01 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-29 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 2/5 | 4/5 | 4/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B- | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B- | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B- | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B- | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sangramjit Sarangi | President & Chief Financial Officer | 41M | male |
| Amit Jhingran | MD, Chief Executive Officer & Director | 20M | male |
| Girish Mahesh Manik | Company Secretary & Compliance Officer | 5M | male |
| Gopikrishna Shenoy | Chief Investment Officer | — | male |
| Prithesh Chaubey | President & Appointed Actuary | — | male |
| Ravindra Sharma | Executive Vice President and Chief of Brand, Corporate Communications & CSR | — | male |
| Smita Verma | Senior Vice President | — | — |
| Subhendu Kumar Bal | President & Chief Risk Officer | — | male |
| Abhijit Gulanikar | President of Operations & Information Technology | — | male |
| Subodh Kumar Jha | EVice President and Chief of Human Resources & Management Services | — | male |
| Anand | President & Chief Distribution Officer | — | male |
| G. Durgadas | President of Operations & IT | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SBILIFE.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
